advertisement

Topcon

Abstract #55442 Published in IGR 15-4

Retinal repair with induced pluripotent stem cells

Al-Shamekh S; Goldberg JL
Translational research : the journal of laboratory and clinical medicine 2014; 163: 377-386


Retinal degeneration such as age-related macular degeneration and other inherited forms, such as Stargardt's disease and retinitis pigmentosa, and optic neuropathies including glaucoma and ischemic optic neuropathy are major causes of vision loss and blindness worldwide. Damage to retinal pigment epithelial cells and photoreceptors in the former, and to retinal ganglion cell axons in the optic nerve and their cell bodies in the retina in the latter diseases lead to the eventual death of these retinal cells, and in humans there is no endogenous replacement or repair. Cell replacement therapies provide 1 avenue to restore function in these diseases, particularly in the case of retinal repair, although there are considerable issues to overcome, including the differentiation and integration of the transplanted cells. What stem cell sources could be used for such therapies? One promising source is induced pluripotent stem cells (iPSCs), which could be drawn from an individual patient needing therapy, or generated and banked from select donors. We review developing research in the use of iPSCs for retinal cell replacement therapy.

Full article

Classification:

2.17 Stem cells (Part of: 2 Anatomical structures in glaucoma)



Issue 15-4

Change Issue


advertisement

Oculus